Blog

The interchangeability of PD-L1 scoring systems and assays in gastroesophageal cancer – EORTC

Photo from EORTC/X

Jul 26, 2024, 15:20

The interchangeability of PD-L1 scoring systems and assays in gastroesophageal cancer – EORTC

EORTC (European Organisation for Research and Treatment of Cancer) shared a post on X:

”Proud to share a new EORTC publication on RP-2321-GITCG ASPIRE, the first global study evaluating the interchangeability of programmed death-ligand 1 (PD-L1) scoring systems and assays in gastroesophageal cancer.

EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol.

Authors: Angelica Petrillo, Lindsey Oudijk, Raghav Sundar, C. Daumer, J. Casas, D. D’haese, Murielle Mauer, Nicole van Grieken, Elizabeth Catherine Smyth, Markus Moehler.”

Source: EORTC/X

Angelica Petrillo C. Daumer cancer Cancer research D. D'haese Elizabeth Catherine Smyth EORTC European Organisation for Research and Treatment of Cancer gastroesophageal cancer J. Casas Lindsey Oudijk Markus Moehler Murielle Mauer ngelica Petrillo Nicole van Grieken OncoDaily Oncology Raghav Sundar

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage